Jabre Capital Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-30,000
Closed -$697K 144
2018
Q2
$697K Buy
+30,000
New +$620K 0.05% 105
2016
Q4
Sell
-415,000
Closed -$10.2M 100
2016
Q3
$10.2M Buy
+415,000
New +$10.7M 1.39% 18

Other funds holding BHC

Jabre Capital Partners's BHC Position: Q3 2018 in Review

Jabre Capital Partners sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 30,000 shares — an estimated $697K sold.

Jabre Capital Partners first reported a position in BHC in Q3 2016 and held it in 2 quarters. The position peaked at $10.2M in Q3 2016. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Jabre Capital Partners reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • Jabre Capital Partners sold 30,000 Bausch Health shares in Q3 2018, an estimated $697K.
  • Jabre Capital Partners first reported a position in Bausch Health in Q3 2016 and held it in 2 quarters.
  • Jabre Capital Partners's Bausch Health position peaked at $10.2M in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Jabre Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.